Authors

Protecting Vulnerable Lives: The Importance of Improving Vaccine Coverage in Patients with Cancer

Generalized Anxiety Disorder Affects More Than 1 in 10 U.S. Adults | AMCP Nexus 2025

New data reveals a rising trend in generalized anxiety disorder (GAD) prevalence among U.S. adults, emphasizing the need for improved diagnosis and treatment.

Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026

Pharmacy Benefits for Today’s Employer Challenges

Sponsored by RxBenefits.

The Shift in Star Ratings That Health Plans Can't Ignore

Transitions of Care (TRC), Medication Reconciliation Post-Discharge (MRP), and Plan All-Cause Readmissions (PCR) are among the measures that have a major effect the Star Rating of health plans.

Bridging the Gap between Providers and Payors Ultimately Benefitting Patients

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.

Cancer and the Microbiome: A Gut Check | ASCO 2025

Gut bacteria produce metabolites that influence drug metabolism and affect immune cell function, potentially enhancing or inhibiting treatment effectiveness.

As Boundaries of Specialty Pharmacy Change, So Must Patient Support Services | Asembia AXS25

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium on leveraging artificial intelligence, technology and cross-functional expertise to create more personalized, efficient patient support services.

AI in Pharmacy: Transforming Workflows and Patient Care

Early Trial of Libtayo Combination Demonstrates Activity in Melanoma

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

How the Move to Digital Pharmacy Addresses Brick and Mortar Closures | Asembia’s AXS25 Summit

Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales and commercialization at HealthDyne and David Skomo, COO of HealthDyne.

Treatment Options for Heart Failure Expands With Finerenone | ACC 2025

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has been studied extensively in patients with mildly reduced or preserved ejection fraction.

Healthcare Is Local: How Proximity Drives Transformation in Dialysis for Underserved Communities

Sponsored by DaVita.

Future Modalities for Infertility

Lucy van de Wiel, PhD, discusses how emerging technologies such as in vitro gametogenesis and gene editing show promise for addressing complex infertility cases, potentially revolutionizing reproductive medicine by offering new solutions for patients with genetic disorders, same-sex couples, and those with uterine factor infertility.

Evaluating Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease: Written Recap

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.

What IRA drug prices will mean for PBMs, health plans and patients

Medicare's first negotiated drug prices, effective January 2026, provide modest discounts, with limited savings for most beneficiaries and some unintended consequences.

Transforming Post-Acute Care into an Integrated, Member-Centric Process

Sponsored Content

2025 Digital Healthcare Outlook: Compliance, Security and Collaboration

Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely to have pronounced impact on nonclinical workflows in 2025.

The Rise of the Modular PBM Model

TAVR Equal to Surgery in Low-Risk Patients with Severe Aortic Stenosis | ACC 2025

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.